115379 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39026)
  2. GSK Faculty (22463)
  3. Solid Tumor Oncology Division (22051)
  4. Surgery (21243)
  5. Sloan Kettering Institute Faculty (16084)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12932)
  10. Department of Pathology and Laboratory Medicine (12602)
Formats
  1. Journal Article (66748)
  2. Meeting Abstract (33628)
  3. Book Section (5027)
  4. Review (3743)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39026)
  2. GSK Faculty (22463)
  3. Solid Tumor Oncology Division (22051)
  4. Surgery (21243)
  5. Sloan Kettering Institute Faculty (16084)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1224)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1983)
  2. 2024 (5385)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115379)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A first-in-human phase 1 trial of dose escalating intrathecal (IT) dendritic cells (cDC1s) primed against HER2/HER3 in patients (pts) with leptomeningeal disease (LMD) from triple-negative (TNBC) or HER2+ breast cancer (BC)
    Meeting Abstract

    Forsyth, P. A. J.; Gandhi, S.; Wilcox, J.; Law, V.; Mo, Q.; Chen, Z.; Ahmed, K. A.; Piteo, C.; Evernden, B.; Pina, Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Updated quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of nivolumab plus chemotherapy versus chemotherapy alone as first-line (1L) treatment for advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma (GC/GEJC/EAC): 4-year (yr) follow-up from CheckMate 649 (CM 649)
    Meeting Abstract

    Lin, D.; Quan, W.; Garretson, M.; Chirikov, V.; Chen, C.; Singh, P.; Davis, C.; Sugarman, R.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Implementing financial toxicity and health-related social risks screening and referral
    Meeting Abstract

    Thom, B.; Aviki, E. M.; Chino, F.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Glucagon-like peptide-1 (GLP-1) agonist use and weight change among patients with breast cancer
    Meeting Abstract

    Shen, S.; Liu, B.; Fanti, C.; Bromberg, M.; Chen, Y.; Chang, C.; Iyengar, N. M.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A multi-institution analysis of outcomes with first-line systemic therapy for 99 patients with metastatic chromophobe renal cell carcinoma
    Meeting Abstract

    Doshi, S. D.; Dizman, N.; Knezevic, A.; Touma, A.; Alaghehbandan, R.; Ged, Y.; Ornstein, M. C.; Hahn, A. W.; Msaouel, P.; Voss, M. H.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Endometrial carcinoma in Black vs Asian women: Racial disparities and opportunities to improve survival in 219,301 patients in the USA
    Meeting Abstract

    Becerra, H. A.; Ilerhunmwuwa, N. P.; Wasifuddin, M.; Uche, I.; Osorio, J. C.; Wang, J. C. C.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real world outcomes of sequential ADC therapy in metastatic breast cancer: Patients treated with sacituzumab govitecan and trastuzumab deruxtecan
    Meeting Abstract

    Mai, N.; Klar, M.; Ferraro, E.; Bromberg, M.; Chen, Y.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Walsh, E. M.; Drago, J. Z.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Cancer care service use intensity in Medicare Advantage versus traditional Medicare
    Meeting Abstract

    Mitchell, A. P.; Kalidindi, Y.; Feldman, R.; Carlin, C.; Song, G.; Jung, J.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • TAZNI: A phase I/II combination trial of tazemetostat with nivolumab and ipilimumab for children with INI1-negative or SMARCA4-deficient tumors
    Meeting Abstract

    Yi, J. S.; Czaplinski, J.; Bhushan, K.; Forrest, S. J.; Shukla, N.; Mack, S. C.; Hong, A. L.; Kentsis, A.; Stinehart, M.; Ezrre, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Characterizing disparities in receipt of palliative care for Asian Americans, Native Hawaiians, and Pacific Islanders with metastatic cancer in the United States
    Meeting Abstract

    Kohli, K.; Kohli, M.; Jain, B.; Swami, N.; Ranganathan, S.; Chino, F.; Iyengar, P.; Yerramilli, D.; Dee, E. C. C.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save